Last Price
Where today's price sits in its 52-week range
Beximco Pharmaceuticals PLC. ওষুধ ও রসায়ন খাতের একটি কোম্পানি। সব মিলিয়ে কোম্পানিটি ভালো অবস্থায় আছে (আমাদের বিশ্লেষণে 100-এর মধ্যে 72)। কোম্পানিটি লাভজনক এবং গত বছরের তুলনায় এর মুনাফা বেড়েছে। একই ধরনের অন্যান্য কোম্পানির তুলনায় এই শেয়ারটির দাম এখন তুলনামূলক কম। কোম্পানিটি নিয়মিতভাবে ডিভিডেন্ড দিয়ে আসছে।
এটি শিক্ষামূলক তথ্য, বিনিয়োগ পরামর্শ নয়।
Buy
Long-term holdGood company, market is buying actively
Five quick checks that tell you whether this company is healthy, fairly priced, and worth holding.
Looks cheap right now — priced below its usual level.
P/E Ratio
11.8
Price per ৳1 of yearly earnings
Dividend Yield
2.60%
Annual cash return on the price
P/B Ratio
1.4
Price per ৳1 of net assets
Trading at 11.8 — below its 5-year average of 12.1.
The raw figures behind the verdict — for the curious.
EPS
৳13.07
Earnings per share (latest year)
P/E Ratio
9.0
Price you pay per ৳1 of earnings
Dividend Yield
2.60%
Annual cash return on the price
Reserve & Surplus
৳3,822 Cr
Company's accumulated savings
Total Loan
৳603 Cr
Outstanding debt the company carries
Are they making money — and do they share it with shareholders?
Yearly Profit
Net profit per year
Made a profit every year for 5 years.
Earnings Per Share
Profit you earn per share
Earnings per share have been growing — ৳13.1 latest.
Yearly Cash Dividend
% of face value
📢 New 47.5% dividend just declared — record 02 Aug 2026
Paid a dividend every year for 5 years running.
The deeper numbers — revenue, margins, debt and cash quality over the years.
What the share price has been doing over the last week.
Up 9.3% in the past week, beating the overall market.
Past week
+9.3%
Price move over 7 days
Vs market
+8.6%
Ahead/behind the DSEX index
Trading volume
1.0×
vs its normal volume
Up days
3/7
Green days this week
52-week spot
98%
Position in 1-year range
Trades around ৳30.8 Cr a day on average over the past week.
The good signs and the things to keep an eye on.
Good signs
BXPHARMA scores below the other strong names in its sector shown here.
| Stock | ||||||
|---|---|---|---|---|---|---|
| MARICO | 84 | ৳2,731 | +0.1% | 14.6 | +14.1% | +78.4% |
| SQURPHARMA | 82 | ৳221 | -0.8% | 8.2 | +5.4% | +14.8% |
| KOHINOOR | 78 | ৳513 | +0.9% | 30.1 | +1.3% | +26.2% |
| RECKITTBEN | 74 | ৳3,326 | +0.2% | 19.2 | +5.2% | +45.4% |
| ACMELAB | 73 | ৳84.5 | +0.4% | 7.4 | +4.1% | +9.1% |
| BXPHARMA | 72 | ৳154 | -0.8% | 11.8 | +2.6% | +11.3% |
Who's behind this company — and how committed are they? As of Mar 2026, compared with Jun 2024.
Worth watching — foreign investors cut their stake from 27.9% to 27.1% since Jun 2024. Keep an eye on why.
Owners (sponsors) hold 30% — a strong sign of commitment.
Recent news and announcements about this company.